- Home
- DYN vs TGLS Comparison
DYN vs TGLS Comparison
Compare DYN & TGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYN | TGLS |
|---|---|---|
| Founded | 1984 | 1984 |
| Country | United States | Colombia |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Electronic Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2020 | 2012 |
Fundamental Metrics
Financial Performance| Metric | DYN | TGLS |
|---|---|---|
| Price | $16.60 | $52.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 1 |
| Target Price | $39.94 | ★ $80.00 |
| AVG Volume (30 Days) | ★ 2.1M | 288.7K |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.13% |
| EPS Growth | N/A | ★ 20.09 |
| EPS | N/A | ★ 3.84 |
| Revenue | N/A | ★ $977,886,000.00 |
| Revenue This Year | N/A | $12.04 |
| Revenue Next Year | N/A | $10.69 |
| P/E Ratio | ★ N/A | $13.86 |
| Revenue Growth | N/A | ★ 15.70 |
| 52 Week Low | $6.36 | $44.26 |
| 52 Week High | $25.00 | $90.34 |
Technical Indicators
Market Signals| Indicator | DYN | TGLS |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 55.16 |
| Support Level | $16.10 | $47.28 |
| Resistance Level | $17.45 | $54.85 |
| Average True Range (ATR) | 1.01 | 1.82 |
| MACD | -0.07 | 0.33 |
| Stochastic Oscillator | 15.50 | 67.24 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About TGLS Tecnoglass Inc.
Tecnoglass Inc is a manufacturer of hi-spec architectural glass and windows for residential and commercial construction industries, operating through its direct and indirect subsidiaries. Its product offerings include tempered glass, laminated glass, thermo-acoustic glass, sliding windows, projecting windows, guillotine windows, sliding doors, loating facades, automatic doors, bathroom dividers, and commercial display windows, among others. The company has one operating segment, Architectural Glass and Windows, which is also its reporting segment. Geographically, the company generates maximum revenue from its customers in the United States, followed by Colombia, Panama, and other regions.